Dianthus Therapeutics Inc.
DNTH
$72.09-3.27%
End of day · as of Oct 17, 2026, 8:00 AM ET
Mkt cap
$4.40B
EV/Sales
2136.6
P/E ratio
N/A
FY2025 Revenue
$2.04M
EPS (TTM)
$-4.24
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-7973.33%
Beta
0.07
Div yield
N/A
Sector
Healthcare
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported DNTH revenue for 2025-12-31 was $2.0M. Net income was -$162.3M. Revenue was down 67.3% from 2024-12-31 to 2025-12-31. DNTH currently screens at market cap $4.40B.
Use this DNTH research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full DNTH income, balance, and cash tables.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company in the Healthcare sector.
Latest cached Dianthus Therapeutics Inc. (DNTH) revenue for Dec 31, 2025 was $2.0M. Net income was -$162.3M. Statements: https://lician.com/financials/dnth
Dianthus Therapeutics Inc. (DNTH) market capitalization is $4.40B on the latest cached snapshot.
Dianthus Therapeutics Inc. (DNTH) cached previous close $74.53; day range $72.09 – $74.41; volume 1,036,409. Session quote: https://lician.com/quote/dnth
Dianthus Therapeutics Inc. (DNTH) latest cached earnings event is "DNTH earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached DNTH filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/dnth